摘要
DNA甲基化与肿瘤临床关系是目前肿瘤分子生物学研究的热点。研究显示,DNA甲基化是非小细胞肺癌(NSCLC)诊断、分期及治疗预后特异性较强的标识物。NSCLC患者血清或呼吸道分泌物DNA甲基化检测标本易于获取,无需切取活体组织,检验技术实用方便,对NSCLC的临床及预后具重要意义。
Clinical relationship between DNA Methlation and tumor is the study hot in oncomolecularbiology at present. Many studies showed that DNA methylation is specific marker of NSCLC in its diagnosis, staging, treatment and prognosis. Samples used for DNA methylation detection from serum and respiratory secretion of patients with NSCLC can be had easily, and DNA methylation detection with utility and convenient needn't exciding living tissue, which has an important significance in the clinic and prognosis of NSCLC.
出处
《医学综述》
2007年第5期344-345,共2页
Medical Recapitulate
关键词
癌
非小细胞肺
DNA甲基化
临床研究
肿瘤转移
预后
Cancer, NSCLC
DNA Methylation
Clinical Research
Tumor metastasis prognosis
Advance